Abstract:Background: Susceptibility to SARS-CoV-2 infection and severity of COVID-19 have high heterogeneity, but the underlying factors for such heterogeneity were largely unknown.Method: Based on the summary statistics from GWAS analyses for immune phenotypes and COVID-19 outcomes, comprehensive analyses (e.g., genetic correlation analysis for detection of the shared genetic components and Mendelian randomization (MR) analyses for causal association inference) were performed to elucidate the associations between 731 immune phenotypes and four COVID-19 outcome pairs.Results: The genetic correlations between COVID-19 outcomes and immune phenotypes were commonly observed, and 60 immune phenotypes were significantly correlated with four COVID-19 outcomes (64 pairs) (FDR < 0.05), among which the COVID-19 severity has the maximum number of significant pairs. Treg T cell panel and B cell panel have relatively more significant pairs in number. Pairwise gene-based analyses identified numerous pleiotropic genes for significant pairs identified. The gene set enrichment analysis revealed the involvement of the identified pleiotropic genes in complex immune processes (e.g., T-cell activation, innate immunity evasion, and cell-specific immune response). We observed significant causal effects of six immune phenotypes from 4 trait panels on any one of the two COVID-19 outcomes (i.e., COVID-19 severity and COVID-19 hospitalization) (FDR < 0.05), and of which CD19 on naïve-mature B cell was the only significant immune phenotype shared by the two COVID-19 outcomes.Conclusion: The more often observed significant correlations showed that the immune responses contribute to COVID-19 outcomes in a very complex pattern, and the differences in immune response among individuals are critical factors for the susceptibility to SARS-CoV-2 infection and severity of COVID-19. The findings greatly improved our understanding of the interaction between immune response and COVID-19 outcome, and also contribute to the detection of susceptible individuals and the design of therapeutic strategies from the perspectives of immunology.Funding Information: The study was supported by the Natural Science Foundation of China 30 (81872681 82173529, 82173598 and 82103922), the Science and Technology Project 31 of Suzhou (SS202050, SYS2019024), the QingLan Research Project of Jiangsu 32 Province, a Project of the Priority Academic Program Development of Jiangsu Higher 33 Education Institutions, and Postgraduate Research & Practice Innovation Program of 34 Jiangsu Province (KYCX22_3227).Declaration of Interests: Xing-Hao Yu, Rong-Rong Cao, Yi-Qun Yang, Han-Wen Cao, Shu-Feng Lei, and Fei-Yan Deng declare that they have no conflicts of interest.

Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines

Identification of Two Novel Candidate Genetic Variants Associated with the Responsiveness to Influenza Vaccination

The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study

Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections

B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses

Genetic Variants in BAT2 Are Associated with Immune Responsiveness to Influenza Vaccination

Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination

Integrated Single-Cell Analysis Revealed Immune Dynamics During Ad5-nCoV Immunization

Genetic determinants of IgG antibody response to COVID-19 vaccination

Immuno-Microbial Signature of Vaccine-Induced Immunity against SARS-CoV-2

Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker

Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population

Weighted gene co-expression network-based identification of genetic effect of mRNA vaccination and previous infection on SARS-CoV-2 infection

Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity

The Crucial Role of Immune Factors in Susceptibility to SARS-CoV-2 Infection and Severity of COVID-19

Single-cell transcriptomic atlas of individuals receiving inactivated COVID-19 vaccines reveals distinct immunological responses between vaccine and natural SARS-CoV-2 infection

Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens

Genetic Determinants of Antibody-Mediated Immune Responses to Infectious Diseases Agents: A Genome-Wide and HLA Association Study

Analysis of Antibodies Induced after SARS-CoV-2 Vaccination Using Antigen Coded Bead Array Luminex Technology

Single-cell Transcriptome Landscape and Antigen Receptor Dynamic During SARS-CoV-2 Vaccination

Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy